MX2025003929A - Composiciones y métodos para la modulación de la actividad de macrófagos - Google Patents

Composiciones y métodos para la modulación de la actividad de macrófagos

Info

Publication number
MX2025003929A
MX2025003929A MX2025003929A MX2025003929A MX2025003929A MX 2025003929 A MX2025003929 A MX 2025003929A MX 2025003929 A MX2025003929 A MX 2025003929A MX 2025003929 A MX2025003929 A MX 2025003929A MX 2025003929 A MX2025003929 A MX 2025003929A
Authority
MX
Mexico
Prior art keywords
modulation
compositions
methods
macrophage activity
human
Prior art date
Application number
MX2025003929A
Other languages
English (en)
Spanish (es)
Inventor
Luca Cassetta
Stephen Myatt
Carola Ries
Krzysztof B Wicher
Original Assignee
Macomics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2023/050592 external-priority patent/WO2023170434A1/en
Application filed by Macomics Ltd filed Critical Macomics Ltd
Publication of MX2025003929A publication Critical patent/MX2025003929A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MX2025003929A 2022-10-04 2025-04-02 Composiciones y métodos para la modulación de la actividad de macrófagos MX2025003929A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB2214614.6A GB202214614D0 (en) 2022-10-04 2022-10-04 Compositions and methods for modulation of macrophage
PCT/GB2023/050592 WO2023170434A1 (en) 2022-03-11 2023-03-13 Compositions and methods for modulation of macrophage activity

Publications (1)

Publication Number Publication Date
MX2025003929A true MX2025003929A (es) 2025-05-02

Family

ID=84000149

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2025003929A MX2025003929A (es) 2022-10-04 2025-04-02 Composiciones y métodos para la modulación de la actividad de macrófagos

Country Status (8)

Country Link
JP (1) JP2025535192A (enExample)
KR (1) KR20250096720A (enExample)
CN (1) CN120435496A (enExample)
AU (1) AU2023232991A1 (enExample)
CR (1) CR20250172A (enExample)
GB (1) GB202214614D0 (enExample)
IL (1) IL319958A (enExample)
MX (1) MX2025003929A (enExample)

Also Published As

Publication number Publication date
JP2025535192A (ja) 2025-10-22
CR20250172A (es) 2025-09-04
IL319958A (en) 2025-05-01
AU2023232991A1 (en) 2025-04-10
CN120435496A (zh) 2025-08-05
KR20250096720A (ko) 2025-06-27
GB202214614D0 (en) 2022-11-16

Similar Documents

Publication Publication Date Title
DOP2024000220A (es) Anticuerpos il-11
CL2020003218A1 (es) Anticuerpos dirigidos contra il-11ra
CY1125539T1 (el) Παραγωγα αζετιδινης ως ρυθμιστες του υποδοχεα χημειοκινης και χρηση αυτων
CO2019010023A2 (es) Compuestos de dinucleótidos cíclicos modificados
MX2021013197A (es) Cicloalquilos sustituidos como moduladores de la vía integrada del estrés.
UA130422C2 (uk) Варіант та ізоформа антитіла зі зниженою біологічною активністю
MX2019009346A (es) Variantes de polipeptidos y usos de los mismos.
SMP201600230B1 (it) Composizione cosmetica
MX375295B (es) Composicion para el cuidado personal que comprende retinoides y silice porosa
CL2021000232S1 (es) Parte de afeitadora.
JP1745670S (ja) カニューレ
WO2019126641A3 (en) Modulation of frataxin expression
CL2021003071A1 (es) Activación de explosivos en agujeros
MX2025003929A (es) Composiciones y métodos para la modulación de la actividad de macrófagos
AR115798A1 (es) Catalizadores para la deshidrogenación oxidativa de alcanos
ZA202300222B (en) Anti-αlpha-4-βeta-7 antibodies
WO2020046769A8 (en) Hematostick/hematodart
EP4299593A4 (en) CLDN18.2 ANTIGEN-BINDING PROTEIN AND ITS USE
JOP20200151A1 (ar) طريقة تصنيع صفيحة تجديد جلد خاص بمريض قدم سكرية وصفيحة تجديد جلد خاص بمريض قدم سكرية مصنعة باستخدام الطريقة ذاتها
JP1735812S (ja) 化粧品用ボトル
EP3856234A4 (en) MODULATION OF GRANZYME K ACTIVITY IN THE TREATMENT OF SKIN CONDITIONS
MX2023011919A (es) Construcciones de proteinas de union a antigenos y anticuerpos y usos de estos.
MX2024004740A (es) Expresión de colágeno y claudina-1 estimulada por la seda, y efectos antiinflamatorios estimulados por la seda.
IT201900022764A1 (it) Prodotto per la cura della pelle e procedimento per la sua realizzazione
MX2025010103A (es) Composiciones y metodos para reducir la adherencia del pelo de mascotas a la tela